FDA Requests Comment on Extension of Label Stock Use for Trans Fat Labeling

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, seeking public comment on an extension of existing label stock use after the January 1, 2006, trans fat labeling effective date.